
The article examines whether psychedelic therapy and traditional antidepressants yield similar improvements in depression when both are studied under open-label conditions, suggesting that study design and expectations may account for some previously observed advantages of psychedelics. It also discusses methodological issues like functional unblinding and the implications for interpreting treatment effectiveness.
This topic is of interest to psychology readers because it highlights how study design, expectations, and placebo-related factors can influence observed treatment outcomes, underscoring the complexity of evaluating novel therapies within mental health research.
Article Title: Psychedelic therapy and traditional antidepressants show similar results under open-label conditions
Link to PsyPost Article: https://www.psypost dot org/psychedelic-therapy-and-traditional-antidepressants-show-similar-results-under-open-label-conditions/
Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.
#psychedelictherapy #depressionresearch #clinicaltrials #openlabel #blindingissues

MDMA and ketamine IV currently have the greatest support in the literature for efficacy in PTSD. Studies suggest treatment with these agents under supervision may lead to improvements in PTSD symptoms, with the medications being generally well tolerated. However, caution should be used when interpre …